HomeCompareCBDS vs EQR

CBDS vs EQR: Dividend Comparison 2026

CBDS yields 6734.01% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBDS wins by $1134331306620783.50M in total portfolio value
10 years
CBDS
CBDS
● Live price
6734.01%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1134331306620783.50M
Annual income
$1,102,135,506,365,417,000,000.00
Full CBDS calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CBDS vs EQR

📍 CBDS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBDSEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBDS + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBDS pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBDS
Annual income on $10K today (after 15% tax)
$572,390.57/yr
After 10yr DRIP, annual income (after tax)
$936,815,180,410,604,500,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, CBDS beats the other by $936,815,180,410,604,500,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBDS + EQR for your $10,000?

CBDS: 50%EQR: 50%
100% EQR50/50100% CBDS
Portfolio after 10yr
$567165653310391.75M
Annual income
$551,067,753,182,708,500,000.00/yr
Blended yield
97.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CBDS
No analyst data
Altman Z
-66.5
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBDS buys
0
EQR buys
0
No recent congressional trades found for CBDS or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBDSEQR
Forward yield6734.01%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$1134331306620783.50M$47.8K
Annual income after 10y$1,102,135,506,365,417,000,000.00$5,475.61
Total dividends collected$1132171482533551.75M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CBDS vs EQR ($10,000, DRIP)

YearCBDS PortfolioCBDS Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$684,101$673,400.67$11,380$679.82+$672.7KCBDS
2$43,785,619$43,053,631.23$13,014$837.25+$43.77MCBDS
3$2,622,207,874$2,575,357,261.36$14,961$1,036.20+$2622.19MCBDS
4$146,947,359,732$144,141,597,307.61$17,297$1,289.22+$146947.34MCBDS
5$7,706,421,362,649$7,549,187,687,735.55$20,121$1,613.15+$7706421.34MCBDS
6$378,250,714,282,047$370,004,843,424,012.75$23,561$2,030.84+$378250714.26MCBDS
7$17,377,416,622,186,412$16,972,688,357,904,620.00$27,783$2,573.54+$17377416622.16MCBDS
8$747,333,345,286,586,900$728,739,509,500,847,500.00$33,013$3,284.39+$747333345286.55MCBDS
9$30,089,532,948,940,880,000$29,289,886,269,484,240,000.00$39,547$4,223.51+$30089532948940.84MCBDS
10$1,134,331,306,620,783,600,000$1,102,135,506,365,417,000,000.00$47,791$5,475.61+$1134331306620783.50MCBDS

CBDS vs EQR: Complete Analysis 2026

CBDSStock

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

Full CBDS Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CBDS vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBDS vs SCHDCBDS vs JEPICBDS vs OCBDS vs KOCBDS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.